Structural heterogeneity of glycans in IgA molecules: Implications for IgA nephropathy

Nephrology

Volumn 3, Issue SUPPL. 2, 1997, Pages s653-s657

  Mestecky, Jiri ^a,b   Tomana, Milan ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Galactose deficiency; Galactosyltransferases; Glycans; IgA nephropathy

Indexed keywords

GALACTOSE; GLYCAN; IMMUNOGLOBULIN A; N ACETYLGALACTOSAMINE;

CARBOHYDRATE ANALYSIS; CONFERENCE PAPER; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0030713352     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1997.tb00280.x     Document Type: Conference Paper

References (54)

1. Varki A. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 1993; 3: 97-130.
2. Imai Y, Singer MS, Fennie C, Lasky LA, Rosen SD. Identification of a carbohydrate-based endothelial ligand for a lymphocyte homing receptor. J. Cell Biol. 1991; 113: 1213-21.
3. Pahlsson P, Strindhall J, Srinivas U, Lundblad A. Role of N-linked glycosylation in expression of E-selectin on human endothelial cells. Eur. J. Immunol. 1995; 25:2452-9.
4. Wold AE, Mestecky J, Tomana M, Kobata A, Ohbayashi H, Endo T. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect. Immun. 1990; 58: 3073-7.
5. Boren T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892-5.
6. Stockert RJ, Kressner MS, Collins JC, Sternlieb I, Morell AG. IgA interactions with the asialoglycoproteins receptor. Proc. Natl Acad. Sci. USA 1982; 79: 6229-33.
7. Tomana M, Kulhavy R, Mestecky J. Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 1988; 94; 762-70.
8. Stockert RJ. The asialoglycoprotein receptor: Relationship between structure, function and expression. Physiol. Rev. 1995; 75: 591-609.
9. Tao M, Morrison SL. Studies of a glycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 1989; 143: 2595-601.
10. Monteiro RC, Kubagawa H, Cooper MD. Cellular distribution, regulation, and biochemical nature of an Fcα receptor in humans. J. Exp. Med. 1990; 171: 597-613.
11. Nose M, Wigzell H. Biological significance of carbohydrate chains on monoclonal antibodies. Proc. Natl Acad. Sci. USA 1983; 80: 6632-7.
12. Nikolova EB, Tomana M, Russell MW. The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA. Immunology 1994; 82: 321-7.
13. Field MC, Amatayakul-Chantler S, Rademacher TW, Rudd PM, Dwek RA. Structural analysis of the N-glycans from human immunoglobulin A1: Comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem. J. 1994; 299: 261-75.
14. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Med.; 1: 237-43.
15. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib. Nephrol. 1993; 104: 172-82.
16. Tomana M. Glycoproteins in inflammatory bowel disease. In: Montreuil J, Vliegenhart JFG, Schachter H, (eds). Glycoproteins in Disease. Elsevier, Amsterdam, 1996; 291-8.
17. Axford JS, Sumar N, Alavi A et al. Changes in normal glycosylation mechanisms in autoimmune rheumatoid disease. J. Clin. Invest. 1992; 89: 1021-31.
18. Rademacher TW, Williams P, Dwek RA. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl Acad. Sci. USA 1994; 91: 6123-7.
19. Hiki Y, Horii A, Iwase H et al. O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy - Fundamental study for precise structure and possible roles. Contrib. Nephrol. 1995; 111: 73-84.
20. Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin. Exp. Immunol. 1995; 100: 470-4.
21. Thurnher M, Fehr J, Berger EG. Differences in the regulation of specific glycosylation in the pathogenesis of paroxysmal nocturnal hemoglobinuria and the Tn-syndrome. Exp. Hematol. 1994; 22: 267-71.
22. Baenziger J, Kornfeld A. Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units. J. Biol. Chem. 1974; 249: 7270-81.
23. Torano A, Tsuzukida Y, Liu Y-S U, Putnam FW. Location and structural significance of the oligosaccharides in human IgA1 and IgA2 immunoglobulins. Proc. Natl Acad. Sci. USA 1977; 74: 2301-5.
24. Field MC, Dwek RA, Edge CJ, Rademacher TW. O-linked oligosaccharides from human serum immunoglobulin A1. Biochem. Soc. Trans. 1989; 17: 1034-5.
25. Iwase H, Tanaka A, Hiki Y et at. Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALD1-TOFMS) analysis of the hinge glycopeptide. J. Biochem. 1996; 120: 393-7.
26. Endo T, Mestecky J, Kulhavy R, Kobata A. Carbohydrate heterogeneity of human myeloma proteins of the IgA1 and IgA2 subclasses. Molec. Immunol. 1994; 31: 1415-22.
27. Mestecky J, Russell MW. IgA subclasses. Monogr. Allergy 1986; 19: 277-301.
28. Kilian M, Mestecky J, Russell MW. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 1988; 52: 296-303.
29. Mellis SJ, Baenziger JU. Structures of the O-glycosidically linked oligosaccharides of human IgD. J. Biol. Chem. 1983; 258: 11557-63.
30. Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J. Clin. Invest. 1980; 66: 1432-6.
31. Russell MW, Mestecky J, Julian BA, Galla JH. IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli. J. Clin. Immunol. 1986; 6: 74-86.
32. Czerkinsky C, Koopman WJ, Jackson S et al. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J. Clin. Invest. 1986; 77: 1931-8.
33. Sinico RA, Fornasieri A, Oreni N, Benuzzi S, D'Amico G. Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease). J. Immunol. 1986; 137: 536-41.
34. Andre PM, Le Pogamp P, Chevet D. Impairment of jacalin binding to serum IgA in IgA nephropathy. J. Clin. Lab. Anal. 1990; 4: 115-9.
35. Wold AE, Motas C, Svanborg C, Mestecky J. Lectin receptors on IgA isotypes. Scand. J. Immunol. 1994; 39: 195-201.
36. Hortin GL. Isolation of glycopeptides containing O-linked oligosaccharides by lectin affinity chromatography on jacalin-agarose. Anal. Biochem. 1990; 191: 262-7.
37. Pilatte Y, Rostocker G, Violleau K, Basta M, Hammer CH. Further identification of human plasma glycoproteins interacting with the galactose-specific lectin Jacalin. J. Chromatogr. B. 1995; 668: 1-11.
38. Mestecky J, Tomana M, Matousovic K, Konecny K, Julian BA. Heterogeneity of carbohydrate moieties of IgA1 molecules from IgA nephropathy patients and normal individuals. Nephrology, 1997; 3: 85-90.
39. Baharaki D, Dueymes M, Perrichot R, Basset C, Le Corre R, Cledes J, Youinou P. Aberrant glycosylation of IgA from patients with IgA nephropathy. Glycoconjug. J. 1996; 13: 505-11.
40. Mestecky J, Hashim OH, Tomana M. Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1. Contrib. Nephrol. 1995; 111: 66-72.
41. Schachter H, Roseman S. Mammalin glycosylatransferases. In: Lennarz WJ (ed.) The Biochemistry of Glycoproteins and Proteoglycans. Plenum Press, New York, 1980: 85-160.
42. Axford JS, Lydyard PM, Isenberg DA, Mackenzie L, Hay FC, Roitt IM. Reduced B cell galactosyltranferase activity in rheumatoid arthritis. Lancet 1988; ii; 1486-8.
43. Furukawa K, Matsuta K, Takeuchi F, Kosuge E, Miyamoto T, Kobata A. Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis. Int. Immunol. 1990; 2: 105-12.
44. Thurnher M, Rusconi S, Berger EG. Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome. J. Clin. Invest. 1993; 91: 2103-10.
45. Opdenakker G, Rudd PM, Wormald MR, Dwek RA, van Damme J. Cells regulate the activities of cytokines by glycosylation. FASEB J. 1995; 9: 453-7.
46. Parekh RB, Dwek RA, Sutton BJ et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in glycosylation pattern of total serum IgG. Nature 1985; 316: 452-7.
47. Tomana M, Schrohenloher RE, Koopman WJ, Alarcon GS, Paul WA. Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthr Rheum. 1989; 31: 333-8.
48. Tomana M, Schrohenloher RE, Reveille JD, Amett FC, Koopman WJ. Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune disease. Rheum Internat. 1993; 12: 191-4.
49. Dube R, Rook GAW, Steele J et al. Agalactosyl IgG in inflammatory bowel disease: Correlation with C-reactive protein. Gut 1990; 31: 431-4.
50. Tsuchiya N, Endo T, Matsuta K et al. Detection of glycosylation abnormality in rheumatoid IgG using N-acetylglucosamine-specific Psathyrella velutina lectin. J. Immunol. 1993; 151: 1137-46.
51. Parekh R, Isenberg D, Rook G, Roitt I, Dwek R, Rademacher T. A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J. Autoimmunity 1989; 2: 101-14.
52. Parekh RB, Roitt IM, Isenherg DA, Dwek RA, Ansell BM, Rademacher TW. Galactosylation of IgG associated oligosaccharides: Reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988; 1: 966-9.
53. Higgins EA, Siminovitch KA, Zhuang D, Brockhausen I, Dennis JW. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J. Biol. Chem. 1991; 266: 6280-90.
54. Dueymes M, Bendaoud B, Pennec YL, Youinou P. IgA glycosylation abnormalities in the serum of patients with primary Sjögren's syndrome. Clin. Exp. Rheumatol. 1995; 13: 247-50.